Bristol Myers Squibb (BMY) Q3 Earnings and Revenues Beat Estimates

What happened: Bristol Myers Squibb ($BMY) reported quarterly earnings of $1.35 per share and revenues of $13.07 billion, beating the Zacks Consensus Estimate on both. Key numbers: EPS $1.35 vs. estimate $1.21, a +11.57% surprise, and $1.63 a year ago. Revenue $13.07 billion vs. estimate beat of 4.07%, and $12.22 billion a year ago. Shares up about 12.3% year to date vs. Why it matters: The company has topped consensus EPS and revenue estimates in each of the last four quarters. The article says the stock's near-term move will depend mostly on management's commentary on the earnings call. Market: -1.6% today ($60.57), +14.5% YTD, 0.6x vol — as of 13:15 UTC Verified: Q3_2026 (Oct 29) EPS $1.35 vs $1.22 est, +10.3% beat; next print ~Jan 28 Coverage: 7 outlets in 24h

Bristol Myers Squibb ($BMY) reported quarterly earnings of $1.35 per share and revenues of $13.07 billion, beating the Zacks Consensus Estimate on both.

The company has topped consensus EPS and revenue estimates in each of the last four quarters. The article says the stock's near-term move will depend mostly on management's commentary on the earnings call. Market: -1.6% today ($60.57), +14.5% YTD, 0.6x vol — as of 13:15 UTC Verified: Q3_2026 (Oct 29) EPS $1.35 vs $1.22 est, +10.3% beat; next print ~Jan 28